NCX-226

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNCX-226
Drug Alias NameNCX-226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsPulmonary FibrosisHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNicox SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox SA
Active IndicationsN/A
Inactive IndicationsPulmonary FibrosisHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A